Research On Chronic Disease Management Industry In China From The Perspective Of Economic Growth

Since the reform and opening up,China's economy has experienced a rapid growth and people's quality of life has been gradually improved.However,the prevalence of chronic diseases in China has been rising rapidly,and getting a younger trend.The high prevalence of chronic diseases has brought great challenges to China's chronic disease management industry.China's Medium-and Long-term Plan for the Prevention and Treatment of Chronic Diseases(2017-2025)clearly states that,China should adhere to the correct health work guidelines,do better in the preventing and controlling chronic diseases to reduce the burden of chronic diseases on residents,and work hard to keep people healthy in an all-round way.Economic growth has brought about changes in residents' lifestyles.The incidence of chronic diseases represented by hypertension and diabetes is higher than that of other chronic diseases,which leads to great loss of national economy and violates the goal of the 19 th National Congress of the Communist Party of China(CPC)to benefit national health through the achievements of economic development.Therefore,from the perspective of economic growth,this paper takes hypertension and diabetes as examples to study the development of chronic disease management industry,and promotes the benefits of economic development to the health of all people.This thesis first summarized the research results of the existing literatures and found that the former research on chronic disease management industry focused on the management mode of the industry,but research on resource allocation of chronic disease management industry is lacking.Therefore,to promote the balanced development of supply and demand of chronic disease management industry,this paper analyzed gaps between the demand and supply of chronic disease management industry caused by the rising prevalence of chronic diseases under economic growth.This paper first studied the ways that economic growth affecting the prevalence of chronic disease based on Grossman health demand model,and found that economic growth leads to an increase of the demand for chronic disease management.Then,merging the individual data of CHARLS from 2011 to 2015 and macroeconomic data of China City Statistical Yearbook from 2012 to 2016 into the panel data.Hypertension and diabetes were selected to measure the prevalence of chronic disease and the economic growth was described by the real growth rate of GDP.Next,the random effects model and the logistic model was adopted to analyze the effects of economic growth on prevalence of chronic disease.The conclusion was that,GDP growth rate increased by 1%,the prevalence of hypertension and its demand for antihypertensive drugs and medical resources would increase by 2.7%,3.8% and 3.6% respectively;GDP growth rate increased by 1%,the prevalence of diabetes and its demand for hypoglycemic drugs and medical resources would increase by 8.9%,1.9% and 8.8% respectively.Current economic growth will increase the prevalence of chronic disease,which means economic growth leads to an increase in the demand for chronic disease management.Based on the demand of chronic disease management generated by economic growth,there are gaps between the supply and demand of China's chronic disease management industry.The central and western regions are lacking of chronic disease management industry;the supply of chronic disease management services in eastern China grows slowly compared with the demand;the market of chronic disease management industry lacks competition;chronic disease management industry lacks prevention and follow-up rehabilitation tracking services.Finally,in order to narrow the gap between supply and demand of chronic diseases management industry,the author proposed the following suggestions.Increase the investment of chronic diseases management in central and western regions in China;improve the management system of chronic diseases in eastern China;encourage private chronic disease management agencies to participate in the market and develop multiple carriers in combination;improve prevention and treatment of chronic diseases,to promote the development of China's chronic disease management industry.